This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Korea University Research and Business Foundation, Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,284 
1 out of 368 Years Active: 2022
Title: Innovations of Chung Ho Kim in Cardiovascular Treatment
Introduction
Chung Ho Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of cardiovascular diseases. His innovative work has led to the development of a unique compound that holds promise for improving health outcomes.
Latest Patents
Chung Ho Kim holds a patent for an N-acylurea derivative and a composition comprising the same for the prevention or treatment of cardiovascular disease. This invention relates to a novel N-acylurea derivative that can inhibit platelet aggregation by targeting the activity of talin in the intracellular matrix. The pharmaceutical composition developed from this derivative serves as an active ingredient for treating cardiovascular conditions.
Career Highlights
Throughout his career, Chung Ho Kim has been associated with prominent research institutions. He has worked with the Korea University Research and Business Foundation and the Kyungpook National University Industry-Academic Cooperation Foundation. His work in these organizations has facilitated advancements in medical research and innovation.
Collaborations
Chung Ho Kim has collaborated with esteemed colleagues, including Soon Jun Hong and Hyung Joon Joo. These partnerships have contributed to the successful development of his innovative solutions in the medical field.
Conclusion
Chung Ho Kim's contributions to cardiovascular treatment through his patented N-acylurea derivative exemplify the impact of innovation in medicine. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile